Gala 2021

It's That Time of Year!

Check out the details and let us know you can join us by registering.
homepage horizontal active

Magician Alan Hudson Headlines Action Awards Virtual Celebration

Alan Hudson's Virtual Magic Show advertisement

For our annual Action Awards Celebration, the Allergy Advocacy Association is delighted to present magician and comedian Alan Hudson, our special guest entertainer on our ZOOM broadcast Wednesday, Oct. 20, 7pm.... Read the article here.

E-Greetings from the Allergy Advocacy Association

March 2020


Due to the COVID-19 virus outbreak in New York State we are CANCELLING our Food Allergy Awareness Day at the Albany State Capital Building on Tuesday, May 5th, 2020. Please mark your calendar accordingly. If the current situation in NYS improves before the current session of the legislature ends in mid-June, we may host a smaller event. We will keep everyone informed.

Regarding new federal legislation, after attending a two day conference and advocacy event hosted by Food Allergy Research Education (FARE) we believe momentum in Washington, DC is increasing. Called the “Courage at Congress Advocacy Day to Fight Food Allergies,” we heard informational sessions on new therapies, defined our legislative priorities, and met with congressman and senators. You can read all the details in the following article.

Lastly, we would like to thank our Epi Everywhere New York (ENYNY) volunteers who work tirelessly to train personnel at day care centers, colleges and other locations on how to recognize the symptoms of anaphylaxis and how to administer an EpiPen. Arranged by project manager Janet Goldman, presentations to date in 2020 have been given by Peter Deane, MD.; Sandra Glantz, MSN, FN; & Jeanne Lomas, MD. We sincerely appreciate all your efforts and know that you are helping to save lives every day.

FARE & Friends Making the Case on Capitol Hill

Two days of attending presentations and advocating with our legislators in Washington, DC gave us a very positive outlook on the future of protecting our love ones who have life-threatening allergies. Read all about the topics discussed and the specific legislation we are advocating for, along with numerous photos of the 150 people of all ages who attended. Next year FARE hopes to fly in five hundred activists and advocates, so Washington will know we will not be ignored!

Members of the New York State FARE contingent at US Capitol building

Edited by Jon Terry
March 11th, 2020

Greetings. On March 3rd and 4th the Food Allergy Research Education (FARE) organization hosted the “Courage at Congress Advocacy Day to Fight Food Allergies.” Your Allergy Advocacy Association proudly participated in conference and lobbying activities.

Continue Reading

UPDATE: Lawsuits against Brand Name and Generic Pharma Companies Move Ahead

Are you ready to join a class action suit against “Big Pharma” for trying to monopolize the epinephrine auto-injector market? A recent ruling by a US District Judge said that numerous lawsuits against the marketers and manufacturers of epinephrine auto-injectors may proceed as a nationwide class-action under a federal racketeering statute. Both brand name and generic drug companies allegedly tried to eliminate competition so they could raise prices by 500% or more. This ruling allows all persons and entities in the US who paid or provided reimbursement for Epi-Pens© as of August 24, 2011, to sue for damages under the federal Racketeer Influenced and Corrupt Organization (RICO) Act. Stay tuned for more details as they become available.

Mylan CEO Heather Bresch testifies before a U.S. House of Representatives Committee

Ruling Allows Millions to Join Lawsuit in Epi-Pen© Racketeering Case

By Dave Bloom

US District Judge Daniel Crabtree ruled yesterday that numerous lawsuits against the marketer and manufacturer of Epi-Pen© may proceed as a nationwide class-action under a federal racketeering statute. His ruling also allows consumers to sue for damages under state antitrust laws.

Continue Reading

Study: Co-Treatments Like Antihistamines and Probiotics Make Peanut OIT Success in Children More Likely

You’ve probably heard of the recent advances in Oral Immunotherapy (OIT) where patients are given very small amounts of peanut protein that do not trigger a reaction, and then increasing the dose over time to increase the amount the body can tolerate. A study by researchers from the University of Adelaide in Australia found that adding antihistamines and probiotics increase the success rate by 10%. Overall, the study found that the treatment worked in around 70% of children, so it might be worth asking your doctor for more information.

Study: Co-Treatments Like Antihistamines and Probiotics Make Peanut OIT Success in Children More Likely

brownish beige tablet in foreground

By  News Wire ~ 3rd Party Press Release

Co-treatments like antihistamines and probiotics make successful de-sensitisation treatment of peanut allergy in children via oral immunotherapy 10 percent more likely, researchers from the University of Adelaide have found.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2020 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions